Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 9, 2025 • 12:01 PM ET

Date/Time Source News Release
05/27/2025 08:00 AM EDT PR Newswire Galmed Identifies Proprietary Biomarker Signature for Aramchol, Unlocking Multi-Billion-Dollar Expansion Potential Beyond NASH
05/22/2025 08:00 AM EDT PR Newswire Galmed Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
05/13/2025 08:00 AM EDT PR Newswire Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in PSC Models
05/06/2025 07:30 AM EDT PR Newswire Galmed Announces First Time Results in Oncology Studies: Aramchol Significantly Enhances Bayer's Regorafenib Effect in GI Cancer Models
04/28/2025 08:00 AM EDT PR Newswire Galmed Signed Term Sheet for the Development of Novel Semaglutide Sublingual Formulation
04/17/2025 08:30 AM EDT PR Newswire Galmed Pharmaceuticals Launches VCU Collaboration to Tackle Drug Resistance in GI Cancers
04/15/2025 08:30 AM EDT PR Newswire Galmed Unveils Novel Pharmacodynamic Blood Markers for Aramchol, the Most Clinically Advanced SCD1 Inhibitor
04/10/2025 08:00 AM EDT PR Newswire Galmed Announces Positive Part 1 Results from the AM-001 Study of Aramchol Meglumine, an Enhanced Formulation of the Most Clinically Advanced SCD1 Inhibitor
04/02/2025 04:10 PM EDT PR Newswire Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024
03/20/2025 08:55 AM EDT PR Newswire Galmed Pharmaceuticals Secures New Patent Grant Extending Aramchol's Patent Protection to 2039, Strengthening Leadership in NASH/MASH Combination Therapy
Page

Additional News

As of June 9, 2025 • 12:01 PM ET

Date/Time Source News Release
05/27/2025 06:47 PM EDT KlickAnalytics GLMD - Historical Price Movements Surrounding Earnings
05/27/2025 06:42 PM EDT KlickAnalytics GLMD - Historical Earnings Price Analysis
05/22/2025 08:06 AM EDT SeekingAlpha Galmed GAAP EPS of -$0.62 beats by $0.27
04/28/2025 02:00 PM EDT PRISM News PRISM Mid-Day Movers: Strategic Deals in Energy and Pharma Contrast Broader Market Cooldown
04/28/2025 11:23 AM EDT InvestorBrandNetwork Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) Sees Notable Increase in Monday Morning Market Activity
04/03/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, April 3rd, 2025
04/03/2025 05:30 AM EDT US Earnings Reports Expected earnings - Galmed Pharmaceuticals Ltd.
04/01/2025 06:44 PM EDT KlickAnalytics GLMD - Historical Earnings Price Analysis
03/17/2025 12:06 PM EDT InvestorBrandNetwork Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) Sees Notable Increase in Monday Morning Market Activity
11/23/2024 04:40 AM EST US Earnings Reports Expected earnings - Galmed Pharmaceuticals Ltd.
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.